Table 3.

Behaviors of REI providers relating to the provision of care to T/GD patients (n = 206).

	Prior training in T/GD health care		P value
	Yes	No
	n (%)	n (%)
Total	105	101
I discuss the impact of hormone therapy (i.e., testosterone/estrogen) on future fertility with my transgender and gender-diverse patients and/or their parents/guardians			.106
Always	65 (69.9)	60 (71.4)
Often	22 (23.7)	13 (15.5)
Sometimes	3 (3.2)	9 (10.7)
Rarely	3 (3.2)	1 (1.2)
Never		1 (1.2)
Missing	12	17
If I have questions about how best to provide care to my transgender and gender-diverse patients, I consult with other infertility specialists or endocrinologists who have more practice experience and/or knowledge about fertility in transgender and gender-diverse patients			.033
No, but I consult other resources (i.e., guidelines and online resources)	10 (10.1)	15 (15.6)
Yes, I consult with my colleagues	87 (87.9)	71 (74)
I do not have colleagues with experience treating transgender and gender-diverse patients		4 (4.2)
Other	2 (2)	6 (6.3)
Missing	6	5
There are resources (such as brochures, handouts, and website/online information) available and offered to transgender and gender-diverse patients in my practice regarding their reproductive health needs and options			<.0001
No	25 (25.3)	54 (56.3)
Yes	53 (53.5)	31 (32.3)
I do not know	21 (21.2)	11 (11.5)
Missing	6	5
I feel comfortable providing counseling about fertility preservation to patients who identify as transgender and gender-diverse			.303
Strongly agree	51 (51.5)	50 (52.1)
Somewhat agree	37 (37.4)	29 (30.2)
Neither agree nor disagree	5 (5.1)	6 (6.3)
Somewhat disagree	6 (6.1)	7 (7.3)
Strongly disagree		4 (4.2)
Missing	6	5

REI = reproductive endocrinology and infertility; T/GD = transgender and gender-diverse.